To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses and important links click here.
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts:
CDC Update on SARS-CoV-2 Surveillance
David Wentworth, PhD
Lead, Surveillance and Emerging Variants Team
COVID-19 Lab Task Force
Director, WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza
Chief, Virology Surveillance and Diagnosis Branch
Centers for Disease Control and Prevention
Delta Variant Update
Jonathan Z. Li, MD
Associate Professor of Medicine
Division of Infectious Diseases
Brigham and Women’s Hospital
Harvard Medical School
The Latest on Vaccines & Immunity
Varun Phadke, MD
Assistant Professor of Medicine, Infectious Diseases
Emory University School of Medicine
Testing for SARS-CoV-2 Immunity
Timothy T. Stenzel, MD, PhD
Director, OHT7: Office of In Vitro Diagnostics and Radiological Health
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
U.S. Food and Drug Administration